Systematic review and meta-analysis of Endostar (rh-endostatin) combined with chemotherapy versus chemotherapy alone for treating advanced non-small cell lung cancer.
about
Matricryptins Network with Matricellular Receptors at the Surface of Endothelial and Tumor CellsNovel endogenous angiogenesis inhibitors and their therapeutic potentialHeparan sulfate signaling in cancerCombined chemotherapy plus endostar with sequential stereotactic radiotherapy as salvage treatment for recurrent esophageal cancer with severe dyspnea: A case report and review of the literature.Effects of common polymorphism rs11614913 in Hsa-miR-196a2 on lung cancer riskThe therapeuatic effect of Endostar on soft carotid plaque neovascularization in patients with non-small cell lung cancer.Compartment-specific expression of collagens and their processing enzymes in intrapulmonary arteries of IPAH patientsThoracic perfusion of recombinant human endostatin (Endostar) combined with chemotherapeutic agents versus chemotherapeutic agents alone for treating malignant pleural effusions: a systematic evaluation and meta-analysisEndostatin's emerging roles in angiogenesis, lymphangiogenesis, disease, and clinical applications.Evaluation of efficacy and safety for recombinant human adenovirus-p53 in the control of the malignant pleural effusions via thoracic perfusion.Pharmacokinetics of PEGylated recombinant human endostatin (M2ES) in ratsIncidence and clinical implication of tumor cavitation in patients with advanced non-small cell lung cancer induced by Endostar, an angiogenesis inhibitor.Comparisons of biophysical properties and bioactivities of mono-PEGylated endostatin and an endostatin analog.Endostatin and endorepellin: A common route of action for similar angiostatic cancer avengersPrognostic performance of inflammation-based prognostic indices in locally advanced non-small-lung cancer treated with endostar and concurrent chemoradiotherapyEfficacy and safety of extended use of platinum-based doublet chemotherapy plus endostatin in patients with advanced nonsmall cell lung cancerUsefulness of dynamic contrast-enhanced magnetic resonance imaging for predicting treatment response to vinorelbine-cisplatin with or without recombinant human endostatin in bone metastasis of non-small cell lung cancer.Combining antiangiogenic therapy with neoadjuvant chemotherapy increases treatment efficacy in stage IIIA (N2) non-small cell lung cancer without increasing adverse effects.Matricryptins and matrikines: biologically active fragments of the extracellular matrix.Conjugation of gold nanoparticles and recombinant human endostatin modulates vascular normalization via interruption of anterior gradient 2-mediated angiogenesis.E-M, an Engineered Endostatin with High ATPase Activity, Inhibits the Recruitment and Alternative Activation of Macrophages in Non-small Cell Lung Cancer.Strategies targeting angiogenesis in advanced non-small cell lung cancer.Endostatin: a promising biomarker in the cardiovascular continuum?In vivo antitumor effect of endostatin-loaded chitosan nanoparticles combined with paclitaxel on Lewis lung carcinoma.A pilot study of combination intraperitoneal recombinant human endostatin and chemotherapy for refractory malignant ascites secondary to ovarian cancer.A randomized Phase III trial of neoadjuvant recombinant human endostatin, docetaxel and epirubicin as first-line therapy for patients with breast cancer (CBCRT01).Predictive and prognostic significance of circulating endothelial cells in advanced non-small cell lung cancer patients.The role of VEGF in the diagnosis and treatment of malignant pleural effusion in patients with non‑small cell lung cancer (Review).A Retrospective Study to Compare Five Induction Chemotherapy Regimens Prior to Radiotherapy in the Reduction of Regional Lymph Node Size in Patients with Nasopharyngeal Carcinoma.Tumor angiogenesis and anti-angiogenic gene therapy for cancer.Comparison of efficacy and toxicity of bevacizumab, endostar and apatinib in transgenic and human lung cancer xenograftzebrafish modelInfluence of different drug delivery methods for Endostar combined with a gemcitabine/cisplatin regimen in locally advanced or metastatic lung squamous cell carcinoma: A retrospective observational study
P2860
Q26766481-F38AB574-1CA9-4D66-A378-79767F6BA491Q26781297-BAF21650-D937-41A6-87BF-0E122EA6B6A5Q28657828-55DC4A00-B825-4B72-A07B-616EFD76C72FQ33778324-E5A252AC-B6AB-4169-B010-91CF98AD455DQ34674523-9415DDB2-3E79-4208-8476-D6AC55132AD5Q35160832-B3A29E5B-A7AD-4535-A651-7B7F2B2B12E3Q35595010-8E435742-A377-45BB-A21A-D92162310793Q36191975-9BCE08A6-8FED-4F4D-BF0C-8B07E69D50F6Q36220259-A2B24254-2570-4EC5-A690-A1D6EB8FA0ADQ36224460-552628FB-9675-4E19-A69B-A925A26A3EB6Q36287721-3A14E243-C000-4D3D-8F44-2D9DCC0146D5Q36439535-FE8255D5-FE17-49E1-99AA-6CA7BDE796A4Q36485789-69582382-407B-4434-86FA-7EE07D4A5F9FQ36578668-FEFFC871-9843-4660-8812-26F495F34FD8Q36824972-9413D9E5-DAA0-4945-80EA-7A139DBA4A0BQ37116858-5E79F344-D6CB-41F5-B632-90060BF4DBC6Q37545124-D3FA1086-F228-47B6-B5CF-93C0322114A8Q37641820-2A36355F-FC3E-48A0-B1EF-3C448979A541Q38210749-DB602E46-A79D-4A3B-97FF-B67F15C98230Q38697147-C7189B1E-D22B-450A-A93B-8FB952E4BCC1Q41352494-A8E24DDA-B4D8-480F-ADEF-60BE76AA3CB2Q41593429-552F3D95-1891-46A2-BC10-10B550828C38Q47667458-157BB91C-9A03-4BDF-BD68-A5BB1C6D763DQ47769437-106B2D7C-4F6A-46A1-9B6E-BBC69FAC3E9DQ48082239-4386BC03-148A-4398-9F59-F43028F3AD1CQ48120524-7813D6CD-A334-4E3D-849C-575250BA4390Q48124045-D95AF4E9-4B4F-4A48-BCEF-36DD70B8FA28Q52564106-593F0727-29BC-44C3-B4DB-0F4576EBD579Q54968036-AD3A6590-AF64-4FE2-B0CA-02C4F1247E67Q55385227-252ABBA5-4EBE-4495-A23A-BEBB6A84CEC0Q58116134-2F5728AB-BE26-4FF6-9793-35737434B231Q58789037-9239AFA8-91AB-47D5-B738-F6EFF295587D
P2860
Systematic review and meta-analysis of Endostar (rh-endostatin) combined with chemotherapy versus chemotherapy alone for treating advanced non-small cell lung cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Systematic review and meta-ana ...... ed non-small cell lung cancer.
@ast
Systematic review and meta-ana ...... ed non-small cell lung cancer.
@en
type
label
Systematic review and meta-ana ...... ed non-small cell lung cancer.
@ast
Systematic review and meta-ana ...... ed non-small cell lung cancer.
@en
prefLabel
Systematic review and meta-ana ...... ed non-small cell lung cancer.
@ast
Systematic review and meta-ana ...... ed non-small cell lung cancer.
@en
P2093
P2860
P31
P921
P356
P1476
Systematic review and meta-ana ...... ed non-small cell lung cancer.
@en
P2093
Biaoxue Rong
Shuanying Yang
Zongjuan Ming
P2860
P2888
P356
10.1186/1477-7819-10-170
P5008
P577
2012-08-24T00:00:00Z
P5875
P6179
1025060857